澤達易盛(688555.SH):對全資子公司增資1.32億元 主要用於支付購買土地款
格隆匯6月7日丨澤達易盛(688555.SH)公吿,為滿足公司對經營場地的需求以及加快公司規模化發展速度、提升公司研發創新能力和市場競爭力及未來發展需要,進一步擴大產能和建設研發中心,杭州暢鴻信息技術有限公司(以下簡稱“杭州暢鴻”)於近日競得餘政儲出[2021]17號地塊國有土地使用權。
為了滿足杭州暢鴻後續支付購買土地款的資金需要,公司擬以自有資金向杭州暢鴻增資1.32億元,本次增資完成後,杭州暢鴻的註冊資本將增至2億元人民幣,本次增資款擬主要用於支付購買土地款,這其中購買土地款項合計金額1.9229億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.